Search
for
Sort by
Research 31–60 of 1000+
- BPS2026 – TMC1 and TMC2 are cholesterol-dependent scramblases that regulate membrane homeostasis in auditory hair cells
- Study on the mechanism that SNPs related to sex hormone metabolism regulate the imbalance of sex hormones and lead to BPH in rats
- The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.
- Scientific augmentation of BPH and its treatment in Unani medicine the review
- Referee report. For: Exploring the use of phytotherapy in benign prostatic hyperplasia [BPH]: a systematic review [version 1; peer review: 2 approved with reservations]
- Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population‐based case–control study
- Anti-BPH lignans from <i>Urtica triangularis</i> subsp. <i>pinnatifida</i> (Hand.-Mazz.) C.J.Chen
- Evaluating Carthamus Oxyacantha For 5α-Reductase Inhibition: Therapeutic Perspectives In BPH
- The relationship of depression, alcohol and marijuana with treatment for LUTS/BPH.
- Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial
- MP27-18 STATEWIDE GEOGRAPHIC PRICE VARIATION OF GENERIC BPH MEDICATIONS
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
- PD59-09 PHOSPHODIESTERASE INHIBITORS COULD REVERSE THE PROLIFERATION OF BPH EPITHELIAL CELLS INDUCED BY CD8+ T CELLS IN LOW ANDROGEN CONDITION
- BPH Medications May Increase Risk of Self-Harm, Depression
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Effects of Castration on BPH
- AB40. Sexual side effects of medical treatment of BPH
- PD23-01 INHIBITOR OF 5A-REDUCTASE TYPES II PROMOTES THE INFILTRATION OF CD8+T CELLS IN BPH TISSUES.
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- Experience of using of Sonirid Duo in treatment of patients with BPH
- Glatze in jungen Jahren könnte Risikofaktor für BPH sein
- Efficacy observation of tamsulosin combined finasteride on delay and prevention the progression of BPH
- Efficacy and safety of long-term administration of tamsulosin hydrochloride in patients with LUTS suggestive of BPH
- S170 DOES STATINS HAVE ANY IMPACT ON THE PROGRESSION OF BPH AND LUTS WHEN COMBINED WITH FINASTERIDE
- Finasteride had fewer sexual side effects compared to dutasteride in men with BPH
- 1424 METHYLATION AND DECREASED EXPRESSION OF 5-ALPHA REDUCTASE 2 IN HUMAN PROSATE SAMPLES: IMPLICATIONS FOR RESISTANCE TO THERAPY FOR BPH
- CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT?
- The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH